Recent News

Testosterone Therapy Drugs and Supplements

Testosterone Drugs Not Effective in Men with Type 2 Diabetes

Testosterone therapy did not help aging, obese men who have Type 2 diabetes and reduced testosterone levels with sexual symptoms and general health, a new study shows. Berlin-based Bayer Pharma AG who makes the testosterone drug Nebido funded the study published in The Journal of Clinical Endocrinology & Metabolism. Researchers found it is unlikely that […]

Jul 28, 2014 Read More...

power morcellation

FDA Pushes for Warning on Power Morcellators, Informed Consent

Members of a specially formed Food and Drug Administration panel say there is not enough evidence to prove using power morcellators to remove uterine fibroids does not increase the risk of spreading undetected cancer – a risk that may be more common than previously thought. During a recent two-day meeting, the FDA health advisors concluded […]

Jul 16, 2014 Read More...

Threads of Zimmer Knee Component

Zimmer Recalls 40,000 NexGen Knee Models

Zimmer Manufacturing initiated another sweeping recall on one of its artificial knee implants, the NexGen MIS Tibial Component, this time because one of the pieces could loosen or fail because of shoddy manufacturing. Zimmer said the threads on the NexGen Complete Knee Solution Tibial Component might be “out of specification” in more than 40,000 devices. […]

Jul 14, 2014 Read More...

Granuflo and Naturalyte, dialysis drugs

Louisiana Files Lawsuit against GranuFlo, NaturaLyte maker Fresenius

The state of Louisiana sued Fresenius Medical Care North America and nearly 100 of its clinics statewide after two of its dialysis drugs – NaturaLyte and GranuFlo – were linked to fatal heart attacks, strokes and other conditions. Louisiana officials claim Fresenius knew that GranuFlo and NaturaLyte could elevate patients’ bicarbonate levels and therefor increase […]

Jul 10, 2014 Read More...

Testosterone Products and Supplements

New Study Favors Testosterone Therapy, Fails to Look at Low T Products

A recently released study shows that the injectable form of low testosterone drugs do not increase the risk of a heart attack in older men. The study is being touted by companies that make so-called “Low-T” products, but it failed to address the more popular forms of this drug – like gels and pills – […]

Jul 9, 2014 Read More...

Viagra May Increase Melanoma Risk

Study Links Viagra to Dangerous Melanoma

Medical researchers are studying a connection between erectile dysfunction medications and melanoma, a deadly form of skin cancer. Using data from the Health Professionals Follow-Up Study (HPFS), doctors found that men using Viagra were 84 percent more likely to develop melanoma than men not using the drug. If a man had used Viagra once but […]

Jun 24, 2014 Read More...

Loading